table of content
1 Study Coverage
1.1 Chemotherapy-Induced Nausea and Vomiting Drugs Product Introduction
1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume for the Year 2017-2028
1.3 United States Chemotherapy-Induced Nausea and Vomiting Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume for the Year 2017-2028
1.4 Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Chemotherapy-Induced Nausea and Vomiting Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Chemotherapy-Induced Nausea and Vomiting Drugs Market Dynamics
1.5.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry Trends
1.5.2 Chemotherapy-Induced Nausea and Vomiting Drugs Market Drivers
1.5.3 Chemotherapy-Induced Nausea and Vomiting Drugs Market Challenges
1.5.4 Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Segment by Type
2.1.1 Existing Drugs
2.1.2 Akynzeo (Netupitant-Palonosetron FDC)
2.1.3 Aloxi (Palonosetron)
2.1.4 Emend (Aprepitant)
2.1.5 Kytril Generic (Granisetron)
2.1.6 Zofran Generic (Ondansetron)
2.1.7 Pipeline Drugs
2.1.8 SUSTOL (Granisetron Injection extended release)
2.1.9 Rolapitant
2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type
2.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type
2.3.1 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Chemotherapy-Induced Nausea and Vomiting Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Segment by Application
3.1.1 Serotonin Receptor Antagonists
3.1.2 NK1 Receptor Antagonists
3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application
3.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application
3.3.1 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Chemotherapy-Induced Nausea and Vomiting Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Competitor Landscape by Company
4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Company
4.1.1 Top Global Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Manufacturer (2017-2022)
4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Concentration Ratio (CR)
4.2.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Chemotherapy-Induced Nausea and Vomiting Drugs in 2021
4.2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Chemotherapy-Induced Nausea and Vomiting Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Company
4.5.1 Top Chemotherapy-Induced Nausea and Vomiting Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Players (2020, 2021 & 2022)
5 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Region
5.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Merck & Co., Inc.
7.1.1 Merck & Co., Inc. Corporation Information
7.1.2 Merck & Co., Inc. Description and Business Overview
7.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
7.1.5 Merck & Co., Inc. Recent Development
7.2 GlaxoSmithKline plc
7.2.1 GlaxoSmithKline plc Corporation Information
7.2.2 GlaxoSmithKline plc Description and Business Overview
7.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
7.2.5 GlaxoSmithKline plc Recent Development
7.3 Tesaro, Inc.
7.3.1 Tesaro, Inc. Corporation Information
7.3.2 Tesaro, Inc. Description and Business Overview
7.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
7.3.5 Tesaro, Inc. Recent Development
7.4 Helsinn Group
7.4.1 Helsinn Group Corporation Information
7.4.2 Helsinn Group Description and Business Overview
7.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
7.4.5 Helsinn Group Recent Development
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Corporation Information
7.5.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
7.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
7.5.5 F. Hoffmann-La Roche Ltd. Recent Development
7.6 Heron Therapeutics, Inc.
7.6.1 Heron Therapeutics, Inc. Corporation Information
7.6.2 Heron Therapeutics, Inc. Description and Business Overview
7.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
7.6.5 Heron Therapeutics, Inc. Recent Development
7.7 Dr. Reddy's Laboratories Ltd.
7.7.1 Dr. Reddy's Laboratories Ltd. Corporation Information
7.7.2 Dr. Reddy's Laboratories Ltd. Description and Business Overview
7.7.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
7.7.5 Dr. Reddy's Laboratories Ltd. Recent Development
7.8 Acacia Pharma
7.8.1 Acacia Pharma Corporation Information
7.8.2 Acacia Pharma Description and Business Overview
7.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
7.8.5 Acacia Pharma Recent Development
7.9 Sun Pharmaceutical Industry Ltd.
7.9.1 Sun Pharmaceutical Industry Ltd. Corporation Information
7.9.2 Sun Pharmaceutical Industry Ltd. Description and Business Overview
7.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
7.9.5 Sun Pharmaceutical Industry Ltd. Recent Development
7.10 Otsuka Holdings Co., Ltd.
7.10.1 Otsuka Holdings Co., Ltd. Corporation Information
7.10.2 Otsuka Holdings Co., Ltd. Description and Business Overview
7.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
7.10.5 Otsuka Holdings Co., Ltd. Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry Chain Analysis
8.2 Chemotherapy-Induced Nausea and Vomiting Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Chemotherapy-Induced Nausea and Vomiting Drugs Distributors
8.3 Chemotherapy-Induced Nausea and Vomiting Drugs Production Mode & Process
8.4 Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Marketing
8.4.1 Chemotherapy-Induced Nausea and Vomiting Drugs Sales Channels
8.4.2 Chemotherapy-Induced Nausea and Vomiting Drugs Distributors
8.5 Chemotherapy-Induced Nausea and Vomiting Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
